{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:12:54Z","timestamp":1761606774825,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903722"],"award-info":[{"award-number":["81903722"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jchromb.2022.123402","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T08:23:56Z","timestamp":1659169436000},"page":"123402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Simultaneous determination and pharmacokinetics study of valsartan, sacubitril and its major metabolite in human plasma, urine and peritoneal dialysis fluid in patients with end-stage renal disease by UPLC\u2013MS\/MS"],"prefix":"10.1016","volume":"1208","author":[{"given":"Ying","family":"Jin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangjie","family":"Di","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisha","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runhan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongsheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenlei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2022.123402_b0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-981-13-8871-2_1","article-title":"Prevalence and Disease Burden of Chronic Kidney Disease","volume":"1165","author":"Lv","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jchromb.2022.123402_b0010","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nrneph.2016.163","article-title":"The global burden of chronic kidney disease: estimates, variability and pitfalls","volume":"13","author":"Glassock","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jchromb.2022.123402_b0015","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","article-title":"Chronic kidney disease: global dimension and perspectives","volume":"382","author":"Jha","year":"2013","journal-title":"Lancet"},{"unstructured":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017, Lancet 395 (2020) 709-733.","key":"10.1016\/j.jchromb.2022.123402_b0020"},{"doi-asserted-by":"crossref","unstructured":"Home Hemodialysis, Indian J. Nephrol. 30 (2020) S87-S88.","key":"10.1016\/j.jchromb.2022.123402_b0025","DOI":"10.4103\/0971-4065.289825"},{"doi-asserted-by":"crossref","unstructured":"A.L. Ammirati, Chronic Kidney Disease, Revista da Associacao Medica Brasileira (1992) 66Suppl 1 (2020) s03-s09.","key":"10.1016\/j.jchromb.2022.123402_b0030","DOI":"10.1590\/1806-9282.66.s1.3"},{"key":"10.1016\/j.jchromb.2022.123402_b0035","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000334153","article-title":"Renal replacement therapy in geriatric end-stage renal disease patients: a clinical approach","volume":"33","author":"Kooman","year":"2012","journal-title":"Blood Purif."},{"doi-asserted-by":"crossref","unstructured":"L.A. Dorantes-Carrillo, M. Medina-Escobedo, Y.A. Cob\u00e1-Canto, A. Alvarez-Baeza, N. M\u00e9ndez Dom\u00ednguez, Morbidity, mortality, and renal replacement therapy for chronic kidney disease in Mexico between 2016 and 2018, Nefrolog\u00eda (2021).","key":"10.1016\/j.jchromb.2022.123402_b0040","DOI":"10.1016\/j.nefro.2020.11.021"},{"issue":"Suppl 1","key":"10.1016\/j.jchromb.2022.123402_b0045","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/01.ASN.0000093239.32602.04","article-title":"Renal replacement therapy in patients with diabetes and end-stage renal disease","volume":"15","author":"Locatelli","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jchromb.2022.123402_b0050","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.2215\/CJN.05500809","article-title":"Kidney transplantation in the context of renal replacement therapy","volume":"4","author":"Pesavento","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jchromb.2022.123402_b0055","first-page":"26","article-title":"Kidney Disease: End-Stage Renal Disease","volume":"509","author":"Braun","year":"2021","journal-title":"FP Essent."},{"doi-asserted-by":"crossref","unstructured":"M. Cozzolino, M. Mangano, A. Stucchi, P. Ciceri, F. Conte, A. Galassi, Cardiovascular disease in dialysis patients, Nephrol. Dial. Transplant. 33 (2018) iii28-iii34.","key":"10.1016\/j.jchromb.2022.123402_b0060","DOI":"10.1093\/ndt\/gfy174"},{"key":"10.1016\/j.jchromb.2022.123402_b0065","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.2169\/internalmedicine.50.5158","article-title":"Analysis of cardiovascular disease in Chinese inpatients with chronic kidney disease","volume":"50","author":"Chen","year":"2011","journal-title":"Int. Med. (Tokyo, Japan)"},{"key":"10.1016\/j.jchromb.2022.123402_b0070","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2215\/CJN.07130810","article-title":"Heart failure in long-term peritoneal dialysis patients: a 4-year prospective analysis","volume":"6","author":"Wang","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jchromb.2022.123402_b0075","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.2215\/CJN.01110307","article-title":"Long-term survival of incident hemodialysis patients who are hospitalized for congestive heart failure, pulmonary edema, or fluid overload","volume":"2","author":"Banerjee","year":"2007","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jchromb.2022.123402_b0080","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0140-6736(12)61272-0","article-title":"Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis","volume":"380","author":"Mahmoodi","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jchromb.2022.123402_b0085","doi-asserted-by":"crossref","first-page":"38768","DOI":"10.1038\/srep38768","article-title":"A nationwide cross-sectional survey on prevalence, management and pharmacoepidemiology patterns on hypertension in Chinese patients with chronic kidney disease","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jchromb.2022.123402_b0090","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/ndt\/14.6.1536","article-title":"Prevalence of hypertension in patients on peritoneal dialysis: results of an Italian multicentre study","volume":"14","author":"Cocchi","year":"1999","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jchromb.2022.123402_b0095","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1093\/eurheartj\/ehv142","article-title":"Role of neprilysin inhibitor combinations in hypertension: insights from hypertension and heart failure trials","volume":"36","author":"Bavishi","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jchromb.2022.123402_b0100","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/0091270009343932","article-title":"Pharmacokinetics and pharmacodynamics of LCZ696, a novel dual-acting angiotensin receptor-neprilysin inhibitor (ARNi)","volume":"50","author":"Gu","year":"2010","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2022.123402_b0105","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/1755-5922.12183","article-title":"Pharmacodynamic and Pharmacokinetic Profiles of Sacubitril\/Valsartan (LCZ696) in Patients with Heart Failure and Reduced Ejection Fraction","volume":"34","author":"Kobalava","year":"2016","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.jchromb.2022.123402_b0110","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/hr.2015.1","article-title":"Safety and efficacy of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Japanese patients with hypertension and renal dysfunction","volume":"38","author":"Ito","year":"2015","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.jchromb.2022.123402_b0115","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00228-016-2072-7","article-title":"Effect of renal function on the pharmacokinetics of LCZ696 (sacubitril\/valsartan), an angiotensin receptor neprilysin inhibitor","volume":"72","author":"Ayalasomayajula","year":"2016","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2022.123402_b0120","first-page":"1","article-title":"Pharmacokinetics and Pharmacodynamics of Sacubitril\/Valsartan in Maintenance Hemodialysis Patients with Heart Failure","author":"Feng","year":"2021","journal-title":"Blood Purif."},{"unstructured":"National Medical Products Administration, Technical guidelines for clinical pharmacokinetics of chemical drugs, 2020.","key":"10.1016\/j.jchromb.2022.123402_b0125"},{"unstructured":"European Medicines Agency, Committee for Medicinal Products for Human Use, Guideline on Bioanalytical Method Validation, 2012.","key":"10.1016\/j.jchromb.2022.123402_b0130"},{"unstructured":"Food and Drug Administration, Guidance for Industry: Analytical Procedures and Methods Validation for Drugs and Biologics, 2018.","key":"10.1016\/j.jchromb.2022.123402_b0135"},{"key":"10.1016\/j.jchromb.2022.123402_b0140","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000519643","article-title":"Pharmacokinetics and Pharmacodynamics of Sacubitril\/Valsartan in Maintenance Hemodialysis Patients with Heart Failure","volume":"51","author":"Feng","year":"2022","journal-title":"Blood Purif."},{"key":"10.1016\/j.jchromb.2022.123402_b0145","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/bmc.3707","article-title":"Development and validation of a reliable and rapid LC-MS\/MS method for simultaneous quantification of sacubitril and valsartan in rat plasma and its application to a pharmacokinetic study","volume":"30","author":"Chunduri","year":"2016","journal-title":"Biomed. Chromatogr."},{"doi-asserted-by":"crossref","unstructured":"P.J. Surya Ayalasomayajula1, P.P. MBChB, D.A. Priyamvada Chandra1, I.R. Thomas Langenickel, G. Sunkara, Assessment of drug interaction potential between lcz696, an angiotensin receptor neprilysin inhibitor, and digoxin or warfarin, Clin. Pharmacol. Biopharm. 04 (2015).","key":"10.1016\/j.jchromb.2022.123402_b0150","DOI":"10.4172\/2167-065X.1000147"},{"key":"10.1016\/j.jchromb.2022.123402_b0155","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s40262-017-0558-9","article-title":"Erratum to: Clinical Pharmacokinetics of Sacubitril\/Valsartan (LCZ696): A Novel Angiotensin Receptor-Neprilysin Inhibitor","volume":"57","author":"Ayalasomayajula","year":"2018","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jchromb.2022.123402_b0160","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3109\/00498254.2015.1014944","article-title":"Disposition and metabolism of [(14)C] Sacubitril\/Valsartan (formerly LCZ696) an angiotensin receptor neprilysin inhibitor, in healthy subjects","volume":"46","author":"Flarakos","year":"2016","journal-title":"Xenobiotica"}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023222003063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023222003063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:08:38Z","timestamp":1761606518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023222003063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":32,"alternative-id":["S1570023222003063"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2022.123402","relation":{},"ISSN":["1570-0232"],"issn-type":[{"type":"print","value":"1570-0232"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simultaneous determination and pharmacokinetics study of valsartan, sacubitril and its major metabolite in human plasma, urine and peritoneal dialysis fluid in patients with end-stage renal disease by UPLC\u2013MS\/MS","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2022.123402","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"123402"}}